+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ophthalmic Drugs Market Research Report by Disease Condition, Dispense Type, Dosage Form, Technology, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4968753
  • Report
  • April 2022
  • Region: Global
  • 206 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Healthcare
  • Alcon, Inc.
  • Allergan Plc
  • Apotex Corporation
  • Bayer
  • Johnson & Johnson
The Global Ophthalmic Drugs Market size was estimated at USD 25.68 billion in 2021, USD 27.06 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.55% to reach USD 35.53 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Ophthalmic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Disease Condition, the market was studied across Allergy, Dry Eye Disorder, Glaucoma, and Retinal Disorder. The Retinal Disorder is further studied across Diabetic Retinopathy, Dry Age-related Macular Degeneration, and Wet Age-related Macular Degeneration.
  • Based on Dispense Type, the market was studied across Over the Counter and Prescription.
  • Based on Dosage Form, the market was studied across Liquid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, Other Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, and Solid Ophthalmic Drug Forms.
  • Based on Technology, the market was studied across Biologics, Cell Therapy, Drug Delivery, Gene Therapy, and Small molecule.
  • Based on Distribution, the market was studied across Drug Stores, Hospital Pharmacies, and Online Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Ophthalmic Drugs market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ophthalmic Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Ophthalmic Drugs Market, including Abbott Healthcare, Aerie Pharmaceuticals, Inc, Alcon, Inc., Allergan Plc, Apotex Corporation, Bayer, Fougera Pharmaceuticals Inc., Greenbrier International, Inc., Johnson & Johnson, Lupin Pharmaceuticals, Inc., Merck & Co., Novartis AG, Pfizer, Inc., Renegeron, Rohto Pharmaceutical Co. Ltd., Santen Pharmaceuticals Company Ltd., Shenzhen ZhiHuiChuangXiang Technology Co., Ltd, TEVA Pharmaceuticals, and Valeant Pharmaceuticals, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Ophthalmic Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ophthalmic Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ophthalmic Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Ophthalmic Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Ophthalmic Drugs Market?
6. What is the market share of the leading vendors in the Global Ophthalmic Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Ophthalmic Drugs Market?
Frequently Asked Questions about the Global Ophthalmic Drugs Market

What is the estimated value of the Global Ophthalmic Drugs Market?

The Global Ophthalmic Drugs Market was estimated to be valued at $25.7 Billion in 2021.

What is the growth rate of the Global Ophthalmic Drugs Market?

The growth rate of the Global Ophthalmic Drugs Market is 5.5%, with an estimated value of $35.5 Billion by 2027.

What is the forecasted size of the Global Ophthalmic Drugs Market?

The Global Ophthalmic Drugs Market is estimated to be worth $35.5 Billion by 2027.

Who are the key companies in the Global Ophthalmic Drugs Market?

Key companies in the Global Ophthalmic Drugs Market include Abbott Healthcare, Aerie Pharmaceuticals, Inc, Alcon, Inc., Allergan Plc, Apotex Corporation, Bayer, Fougera Pharmaceuticals Inc., Greenbrier International, Inc. and Lupin Pharmaceuticals, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Healthcare
  • Alcon, Inc.
  • Allergan Plc
  • Apotex Corporation
  • Bayer
  • Johnson & Johnson

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in prevalence of ophthalmic disorders and indications globally
5.1.1.2. Collaborative focus of key players to develop combination therapies for the treatment of ophthalmic disorders
5.1.1.3. Increased awareness, treatment accessibility and drug availability
5.1.2. Restraints
5.1.2.1. Time taking research and development of ophthalmic drugs
5.1.3. Opportunities
5.1.3.1. Increase in investment of vendor in emerging economies
5.1.3.2. Development of generics and biosimilars
5.1.4. Challenges
5.1.4.1. Unmonitored side effects
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Ophthalmic Drugs Market, by Disease Condition
6.1. Introduction
6.2. Allergy
6.3. Dry Eye Disorder
6.4. Glaucoma
6.5. Retinal Disorder
6.5.1. Diabetic Retinopathy
6.5.2. Dry Age-related Macular Degeneration
6.5.3. Wet Age-related Macular Degeneration
7. Ophthalmic Drugs Market, by Dispense Type
7.1. Introduction
7.2. Over the Counter
7.3. Prescription
8. Ophthalmic Drugs Market, by Dosage Form
8.1. Introduction
8.2. Liquid Ophthalmic Drug Forms
8.3. Multicompartment Drug Delivery Systems
8.4. Other Ophthalmic Drug Forms
8.5. Semisolid Ophthalmic Drug Forms
8.6. Solid Ophthalmic Drug Forms
9. Ophthalmic Drugs Market, by Technology
9.1. Introduction
9.2. Biologics
9.3. Cell Therapy
9.4. Drug Delivery
9.5. Gene Therapy
9.6. Small molecule
10. Ophthalmic Drugs Market, by Distribution
10.1. Introduction
10.2. Drug Stores
10.3. Hospital Pharmacies
10.4. Online Pharmacies
11. Americas Ophthalmic Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Ophthalmic Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
13. Europe, Middle East & Africa Ophthalmic Drugs Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Healthcare
15.2. Aerie Pharmaceuticals, Inc
15.3. Alcon, Inc.
15.4. Allergan Plc
15.5. Apotex Corporation
15.6. Bayer
15.7. Fougera Pharmaceuticals Inc.
15.8. Greenbrier International, Inc.
15.9. Johnson & Johnson
15.10. Lupin Pharmaceuticals, Inc.
15.11. Merck & Co.
15.12. Novartis AG
15.13. Pfizer, Inc.
15.14. Renegeron
15.15. Rohto Pharmaceutical Co. Ltd.
15.16. Santen Pharmaceuticals Company Ltd.
15.17. Shenzhen ZhiHuiChuangXiang Technology Co., Ltd
15.18. TEVA Pharmaceuticals
15.19. Valeant Pharmaceuticals, Inc.
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL OPHTHALMIC DRUGS MARKET: DYNAMICS
FIGURE 2. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2021 VS 2027 (%)
FIGURE 3. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2027
FIGURE 5. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ALLERGY, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ALLERGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE DISORDER, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE DISORDER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DIABETIC RETINOPATHY, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2021 VS 2027 (%)
FIGURE 20. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2027
FIGURE 22. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OVER THE COUNTER, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (%)
FIGURE 27. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (USD BILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2027
FIGURE 29. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY LIQUID OPHTHALMIC DRUG FORMS, 2019-2027 (USD BILLION)
FIGURE 30. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY LIQUID OPHTHALMIC DRUG FORMS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY MULTICOMPARTMENT DRUG DELIVERY SYSTEMS, 2019-2027 (USD BILLION)
FIGURE 32. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY MULTICOMPARTMENT DRUG DELIVERY SYSTEMS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 33. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OTHER OPHTHALMIC DRUG FORMS, 2019-2027 (USD BILLION)
FIGURE 34. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OTHER OPHTHALMIC DRUG FORMS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SEMISOLID OPHTHALMIC DRUG FORMS, 2019-2027 (USD BILLION)
FIGURE 36. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SEMISOLID OPHTHALMIC DRUG FORMS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 37. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SOLID OPHTHALMIC DRUG FORMS, 2019-2027 (USD BILLION)
FIGURE 38. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SOLID OPHTHALMIC DRUG FORMS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 39. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 40. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 42. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY BIOLOGICS, 2019-2027 (USD BILLION)
FIGURE 43. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 44. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY CELL THERAPY, 2019-2027 (USD BILLION)
FIGURE 45. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY CELL THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 46. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG DELIVERY, 2019-2027 (USD BILLION)
FIGURE 47. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 48. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GENE THERAPY, 2019-2027 (USD BILLION)
FIGURE 49. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GENE THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 50. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SMALL MOLECULE, 2019-2027 (USD BILLION)
FIGURE 51. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 52. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 53. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD BILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 55. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG STORES, 2019-2027 (USD BILLION)
FIGURE 56. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 57. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 58. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 59. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD BILLION)
FIGURE 60. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 61. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. CANADA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. MEXICO OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. AUSTRALIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. CHINA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. INDIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. INDONESIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. JAPAN OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. MALAYSIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. PHILIPPINES OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. SINGAPORE OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 77. TAIWAN OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 78. THAILAND OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 79. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 80. FRANCE OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 81. GERMANY OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 82. ITALY OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 83. NETHERLANDS OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 84. QATAR OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 85. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 86. SAUDI ARABIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 87. SOUTH AFRICA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 88. SPAIN OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 89. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 90. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 91. GLOBAL OPHTHALMIC DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 92. GLOBAL OPHTHALMIC DRUGS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 93. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL OPHTHALMIC DRUGS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL OPHTHALMIC DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISEASE CONDITION, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ALLERGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY ALLERGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY ALLERGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE DISORDER, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE DISORDER, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DRY EYE DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY RETINAL DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DIABETIC RETINOPATHY, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 32. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DRY AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 35. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 37. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY WET AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISPENSE TYPE, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY OVER THE COUNTER, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY PRESCRIPTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD BILLION)
TABLE 51. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY LIQUID OPHTHALMIC DRUG FORMS, BY REGION, 2019-2027 (USD BILLION)
TABLE 52. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY LIQUID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY LIQUID OPHTHALMIC DRUG FORMS, BY STATE, 2019-2027 (USD BILLION)
TABLE 54. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY LIQUID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY LIQUID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY MULTICOMPARTMENT DRUG DELIVERY SYSTEMS, BY REGION, 2019-2027 (USD BILLION)
TABLE 57. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY MULTICOMPARTMENT DRUG DELIVERY SYSTEMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY MULTICOMPARTMENT DRUG DELIVERY SYSTEMS, BY STATE, 2019-2027 (USD BILLION)
TABLE 59. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY MULTICOMPARTMENT DRUG DELIVERY SYSTEMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY MULTICOMPARTMENT DRUG DELIVERY SYSTEMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY OTHER OPHTHALMIC DRUG FORMS, BY REGION, 2019-2027 (USD BILLION)
TABLE 62. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY OTHER OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 63. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY OTHER OPHTHALMIC DRUG FORMS, BY STATE, 2019-2027 (USD BILLION)
TABLE 64. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY OTHER OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY OTHER OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SEMISOLID OPHTHALMIC DRUG FORMS, BY REGION, 2019-2027 (USD BILLION)
TABLE 67. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY SEMISOLID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 68. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY SEMISOLID OPHTHALMIC DRUG FORMS, BY STATE, 2019-2027 (USD BILLION)
TABLE 69. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY SEMISOLID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY SEMISOLID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 71. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SOLID OPHTHALMIC DRUG FORMS, BY REGION, 2019-2027 (USD BILLION)
TABLE 72. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY SOLID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 73. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY SOLID OPHTHALMIC DRUG FORMS, BY STATE, 2019-2027 (USD BILLION)
TABLE 74. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY SOLID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY SOLID OPHTHALMIC DRUG FORMS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
TABLE 77. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 78. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 79. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY BIOLOGICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 80. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 82. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY CELL THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 83. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 84. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY CELL THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 85. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 87. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2019-2027 (USD BILLION)
TABLE 88. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 89. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DRUG DELIVERY, BY STATE, 2019-2027 (USD BILLION)
TABLE 90. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 92. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY GENE THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 93. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 94. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY GENE THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 95. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 97. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2019-2027 (USD BILLION)
TABLE 98. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 99. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY SMALL MOLECULE, BY STATE, 2019-2027 (USD BILLION)
TABLE 100. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 102. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD BILLION)
TABLE 103. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2019-2027 (USD BILLION)
TABLE 104. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 105. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY DRUG STORES, BY STATE, 2019-2027 (USD BILLION)
TABLE 106. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 108. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 109. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 110. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 111. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 113. GLOBAL OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 114. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 115. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 116. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 118. AMERICAS OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 119. ARGENTINA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 120. BRAZIL OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 121. CANADA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 122. MEXICO OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 123. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 124. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 125. AUSTRALIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 126. CHINA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 127. INDIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 128. INDONESIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 129. JAPAN OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 130. MALAYSIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 131. PHILIPPINES OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 132. SINGAPORE OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 133. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 134. TAIWAN OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 135. THAILAND OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 137. FRANCE OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 138. GERMANY OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 139. ITALY OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 140. NETHERLANDS OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 141. QATAR OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 142. RUSSIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 143. SAUDI ARABIA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 144. SOUTH AFRICA OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 145. SPAIN OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 146. UNITED ARAB EMIRATES OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 147. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 148. GLOBAL OPHTHALMIC DRUGS MARKET: SCORES
TABLE 149. GLOBAL OPHTHALMIC DRUGS MARKET: BUSINESS STRATEGY
TABLE 150. GLOBAL OPHTHALMIC DRUGS MARKET: PRODUCT SATISFACTION
TABLE 151. GLOBAL OPHTHALMIC DRUGS MARKET: RANKING
TABLE 152. GLOBAL OPHTHALMIC DRUGS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 153. GLOBAL OPHTHALMIC DRUGS MARKET: MERGER & ACQUISITION
TABLE 154. GLOBAL OPHTHALMIC DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 155. GLOBAL OPHTHALMIC DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 156. GLOBAL OPHTHALMIC DRUGS MARKET: INVESTMENT & FUNDING
TABLE 157. GLOBAL OPHTHALMIC DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 158. GLOBAL OPHTHALMIC DRUGS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Healthcare
  • Aerie Pharmaceuticals, Inc
  • Alcon, Inc.
  • Allergan Plc
  • Apotex Corporation
  • Bayer
  • Fougera Pharmaceuticals Inc.
  • Greenbrier International, Inc.
  • Johnson & Johnson
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co.
  • Novartis AG
  • Pfizer, Inc.
  • Renegeron
  • Rohto Pharmaceutical Co. Ltd.
  • Santen Pharmaceuticals Company Ltd.
  • Shenzhen ZhiHuiChuangXiang Technology Co., Ltd
  • TEVA Pharmaceuticals
  • Valeant Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...